MDxHealth CEO to Keynote at Biomarkers from Research to Clinic Conference
News Jan 05, 2015
MDxHealth SA has announced that its CEO, Dr Jan Groen, will deliver a keynote presentation at the Biomarkers from Research to Clinic, Prognostic, Predictive & Point-of-Care Conference at 13:15 PST on January 15 in San Diego, CA, USA.
The presentation, "Epigenetic Biomarkers in Oncology", will highlight the development and commercialization of epigenetic diagnostic tests, several of which are now commercially available and used routinely in clinical practice.
All cancers show epigenetic changes. Measuring the epigenetic changes associated with specific genes can help guide physicians in the management of a patient's disease. With continued market adoption of the ConfirmMDx® for Prostate Cancer test, the inclusion of PredictMDx® for Glioblastoma into the NCCN guidelines, and the launch of Cologuard® for colon cancer by licensee Exact Sciences, there are now three successful diagnostic tests on the U.S. market using MDxHealth's epigenetic technology and biomarkers.
Scientists at McGill have found the answer to a question that perplexed Charles Darwin; if natural selection works at the level of the individual, fighting for survival and reproduction, how can a single colony produce worker ants that are so dramatically different in size – from “minor” workers to large-headed soldiers with huge mandibles – especially if they are sterile?
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019
12th Edition of International Conference on Infectious Diseases
Apr 22 - Apr 23, 2019